Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
 
You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
 
    1
ATC Name B/G Ingredients Dosage Form ↑ Price
L01ED01 XALKORI B Crizotinib - 250mg 250mg Capsule 5,702,209 L.L
L01ED01 XALKORI B Crizotinib - 200mg 200mg Capsule 5,702,209 L.L
A08AB01 XENICAL B Orlistat - 120mg 120mg Capsule 4,059,455 L.L
L01ED01 XALKORI B Crizotinib - 250mg 250mg Capsule 349,586,207 L.L
L01ED01 XALKORI B Crizotinib - 200mg 200mg Capsule 349,586,207 L.L
L02BB04 XTANDI B Enzalutamide - 40mg 40mg Capsule, soft 4,261,416 L.L
L02BB04 XTANDI B Enzalutamide - 40mg 40mg Capsule, soft 261,255,338 L.L
D07AC13 XEMADERM G Mometasone furoate - 0.1% 0.1% Cream 337,838 L.L
S01ED51 XOLAMOL G Timolol (maleate) - 5mg/ml, Dorzolamide HCl - 20mg/ml Drops solution 682,432 L.L
S01ED51 XALACOM B Timolol (maleate) - 6.8mg/ml, Latanoprost - 50?g/ml Drops solution 513,513 L.L
S01EE01 XALATAN B Latanoprost - 50mcg/ml 50mcg/ml Drops solution 708,107 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 250IU 250IU Injectable lyophilised powder for solution+diluent 3,264,169 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 500IU 500IU Injectable lyophilised powder for solution+diluent 637,349 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 1000IU 1000IU Injectable lyophilised powder for solution+diluent 680,101 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 2000IU 2000IU Injectable lyophilised powder for solution+diluent 1,244,829 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 500IU 500IU Injectable lyophilised powder for solution+diluent 38,978,755 L.L
R03DX05 XOLAIR BioTech Omalizumab - 150mg 150mg Injectable lyophilised powder for solution+diluent 825,193 L.L
R03DX05 XOLAIR BioTech Omalizumab - 150mg 150mg Injectable lyophilised powder for solution+diluent 50,590,216 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 100 units LD50 100 units LD50 Injectable powder for solution 20,632,164 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 50 units LD50 50 units LD50 Injectable powder for solution 11,986,702 L.L
M05BX04 XGEVA BioTech Denosumab - 120mg 120mg Injectable solution 35,317,536 L.L
A10AE56 XULTOPHY BioTech Insulin degludec - 100U/ml, Liraglutide - 3.6mg/ml Injectable solution 5,658,036 L.L
R03DX05 XOLAIR BioTech Omalizumab - 150mg 150mg Injectable solution 608,706 L.L
R03DX05 XOLAIR BioTech Omalizumab - 75mg 75mg Injectable solution 8,025,658 L.L
R03DX05 XOLAIR BioTech Omalizumab - 150mg 150mg Injectable solution 37,318,046 L.L
R03DX05 XOLAIR BioTech Omalizumab - 75mg 75mg Injectable solution 19,261,580 L.L
R01AA07 XYLO-COMOD G Xylometazoline HCl - 0.1% 0.1% Solution 502,702 L.L
H02AB06 XILONE FORTE G Prednisolone sodium phosphate - 15mg/5ml 15mg/5ml Solution 416,216 L.L
D04AB01 XYLOCAINE B Lidocaine - 10mg/spray dose 100mg/ml Spray 766,215 L.L
D04AB01 XYLOCAINE B Lidocaine - 10mg/spray dose 100mg/ml Spray 766,215 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2024